FDA Inspection 1004928 — Dr. Beat Hintermann
The FDA completed an inspection of Dr. Beat Hintermann on Jan 13, 2017 in Liestal. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 13, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Liestal (Switzerland)
Additional Details
Clinical Investigator (CI)